id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02844907
|
1:20:chronic_disease,,
|
Renal insufficiency (eGFR < 60 mL/kg/min)
| 3
|
[
"Renal",
"insufficiency",
"(",
"eGFR",
"<",
"60",
"mL/kg/min",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT01851694
|
8:24:chronic_disease,40:59:chronic_disease
|
Severe CF liver disease, as defined by portal hypertension
| 3
|
[
"Severe",
"CF",
"liver",
"disease",
",",
"as",
"defined",
"by",
"portal",
"hypertension"
] |
[
0,
2,
2,
2,
0,
0,
0,
0,
2,
2
] |
NCT02058095
|
13:33:treatment,
|
Received an investigational drug within 1 month prior to dosing
| 3
|
[
"Received",
"an",
"investigational",
"drug",
"within",
"1",
"month",
"prior",
"to",
"dosing"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01871727
|
15:28:cancer
|
Lead-In Part: Stage IA - IV, except participants with CNS involvement
| 3
|
[
"Lead-In",
"Part",
":",
"Stage",
"IA",
"-",
"IV",
",",
"except",
"participants",
"with",
"CNS",
"involvement"
] |
[
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT02811510
|
,35:43:treatment
|
At least one lifetime exposure to cannabis
| 3
|
[
"At",
"least",
"one",
"lifetime",
"exposure",
"to",
"cannabis"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT01554371
|
27:35:treatment
|
Patients with non-healing surgical wounds
| 3
|
[
"Patients",
"with",
"non-healing",
"surgical",
"wounds"
] |
[
0,
0,
0,
1,
0
] |
NCT02132130
|
1:16:chronic_disease
|
cochlea aplasia
| 3
|
[
"cochlea",
"aplasia"
] |
[
2,
2
] |
NCT02424929
|
1:12:chronic_disease,38:46:chronic_disease,62:84:treatment,106:113:chronic_disease,128:131:treatment
|
Parkinson's patients with concurrent dementia as measured by neurocognitive testing, or with significant strokes identified on MRI
| 3
|
[
"Parkinson",
"'s",
"patients",
"with",
"concurrent",
"dementia",
"as",
"measured",
"by",
"neurocognitive",
"testing",
",",
"or",
"with",
"significant",
"strokes",
"identified",
"on",
"MRI"
] |
[
2,
2,
2,
2,
2,
2,
2,
2,
2,
1,
1,
2,
2,
2,
2,
2,
2,
2,
1
] |
NCT03153410
|
1:14:treatment,,72:83:treatment,85:96:treatment,105:124:treatment,130:153:treatment
|
Major surgery 28 days prior to study entry excluding minor procedures (dental work, skin biopsy, etc.), celiac plexus block, and biliary stent placement
| 3
|
[
"Major",
"surgery",
"28",
"days",
"prior",
"to",
"study",
"entry",
"excluding",
"minor",
"procedures",
"(",
"dental",
"work",
",",
"skin",
"biopsy",
",",
"etc",
".",
")",
",",
"celiac",
"plexus",
"block",
",",
"and",
"biliary",
"stent",
"placement"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
1,
1,
1
] |
NCT02335242
|
29:32:treatment
|
Have no contraindication to MRI examinations such as metal implants, etc
| 3
|
[
"Have",
"no",
"contraindication",
"to",
"MRI",
"examinations",
"such",
"as",
"metal",
"implants",
",",
"etc"
] |
[
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02680574
|
25:36:treatment,
|
Currently maintained on ESA therapy, with a dose received within 6 weeks prior to or during Screening
| 3
|
[
"Currently",
"maintained",
"on",
"ESA",
"therapy",
",",
"with",
"a",
"dose",
"received",
"within",
"6",
"weeks",
"prior",
"to",
"or",
"during",
"Screening"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02700009
|
1:9:chronic_disease,19:42:chronic_disease,79:83:treatment
|
Dementia or other organic brain disorders that would prevent participation in CCBT
| 3
|
[
"Dementia",
"or",
"other",
"organic",
"brain",
"disorders",
"that",
"would",
"prevent",
"participation",
"in",
"CCBT"
] |
[
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
1
] |
NCT00720785
|
1:14:chronic_disease,
|
Hypercalcemia greater than 2.5 mmol/L
| 3
|
[
"Hypercalcemia",
"greater",
"than",
"2.5",
"mmol/L"
] |
[
2,
0,
0,
0,
0
] |
NCT02946892
|
1:16:chronic_disease,,
|
Hypoalbuminemia defined as serum albumin <2.0g/dL
| 3
|
[
"Hypoalbuminemia",
"defined",
"as",
"serum",
"albumin",
"<",
"2.0g/dL"
] |
[
2,
0,
0,
0,
0,
0,
0
] |
NCT01542879
|
40:51:treatment
|
Pt with iron-overload will not receive Ferumoxytol
| 3
|
[
"Pt",
"with",
"iron-overload",
"will",
"not",
"receive",
"Ferumoxytol"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT01174121
|
15:43:cancer,63:74:treatment,78:88:treatment
|
Patients with metastatic colorectal cancer must have received oxaliplatin or irinotecan
| 3
|
[
"Patients",
"with",
"metastatic",
"colorectal",
"cancer",
"must",
"have",
"received",
"oxaliplatin",
"or",
"irinotecan"
] |
[
0,
0,
3,
3,
3,
0,
0,
0,
1,
0,
1
] |
NCT01269034
|
1:27:chronic_disease
|
inflammatory bowel disease
| 3
|
[
"inflammatory",
"bowel",
"disease"
] |
[
2,
2,
2
] |
NCT02272998
|
36:58:chronic_disease,60:82:chronic_disease,86:104:chronic_disease
|
Patients with history of recurrent venous thromboembolism (deep venous thrombosis or pulmonary embolism) or history of venous thromboembolism
| 3
|
[
"Patients",
"with",
"history",
"of",
"recurrent",
"venous",
"thromboembolism",
"(",
"deep",
"venous",
"thrombosis",
"or",
"pulmonary",
"embolism",
")",
"or",
"history",
"of",
"venous",
"thromboembolism"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02710240
|
28:37:cancer
|
Patients presenting with a CNS tumor presumed to be resectable and are at risk for local recurrence on pre-operative assessment
| 3
|
[
"Patients",
"presenting",
"with",
"a",
"CNS",
"tumor",
"presumed",
"to",
"be",
"resectable",
"and",
"are",
"at",
"risk",
"for",
"local",
"recurrence",
"on",
"pre-operative",
"assessment"
] |
[
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02128906
|
41:57:cancer
|
Patients with simultaneous primaries or bilateral tumors are excluded
| 3
|
[
"Patients",
"with",
"simultaneous",
"primaries",
"or",
"bilateral",
"tumors",
"are",
"excluded"
] |
[
0,
0,
0,
0,
0,
3,
3,
0,
0
] |
NCT03095118
|
1:13:treatment,62:68:chronic_disease,72:77:chronic_disease
|
Renal biopsy read at Mayo Clinic confirming the diagnosis of PGNMID or C3 GN
| 3
|
[
"Renal",
"biopsy",
"read",
"at",
"Mayo",
"Clinic",
"confirming",
"the",
"diagnosis",
"of",
"PGNMID",
"or",
"C3",
"GN"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2
] |
NCT00540761
|
8:16:chronic_disease
|
active ischemia
| 3
|
[
"active",
"ischemia"
] |
[
0,
2
] |
NCT02498613
|
12:33:chronic_disease,
|
History of myocardial infarction within 6 months prior to registration
| 3
|
[
"History",
"of",
"myocardial",
"infarction",
"within",
"6",
"months",
"prior",
"to",
"registration"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02304458
|
24:45:cancer,37:45:cancer,49:68:cancer,93:112:cancer
|
Part B7: patients with unresectable melanoma or metastatic melanoma or relapsed melanoma or refractory melanoma
| 3
|
[
"Part",
"B7",
":",
"patients",
"with",
"unresectable",
"melanoma",
"or",
"metastatic",
"melanoma",
"or",
"relapsed",
"melanoma",
"or",
"refractory",
"melanoma"
] |
[
0,
0,
0,
0,
0,
3,
3,
0,
3,
3,
0,
0,
0,
0,
3,
3
] |
NCT02848417
|
1:23:chronic_disease
|
Inflammatory disorders
| 3
|
[
"Inflammatory",
"disorders"
] |
[
2,
2
] |
NCT01184547
|
1:20:chronic_disease
|
Autoimmune Diseases
| 3
|
[
"Autoimmune",
"Diseases"
] |
[
2,
2
] |
NCT03110354
|
8:30:chronic_disease,41:64:treatment,66:76:treatment,81:92:treatment,100:138:chronic_disease,163:196:chronic_disease
|
Has an uncontrolled infection requiring intravenous antibiotics, antivirals, or antifungals, known human immunodeficiency virus infection, or tested positive for active hepatitis B or C infection
| 3
|
[
"Has",
"an",
"uncontrolled",
"infection",
"requiring",
"intravenous",
"antibiotics",
",",
"antivirals",
",",
"or",
"antifungals",
",",
"known",
"human",
"immunodeficiency",
"virus",
"infection",
",",
"or",
"tested",
"positive",
"for",
"active",
"hepatitis",
"B",
"or",
"C",
"infection"
] |
[
0,
0,
2,
2,
0,
1,
1,
0,
1,
0,
0,
1,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
2
] |
NCT03115398
|
1:18:treatment,,42:52:treatment,54:80:treatment,97:109:treatment,114:123:treatment,130:145:treatment,157:196:treatment
|
Planned treatment with fractionated (≥15 treatments) external beam radiotherapy with concurrent chemotherapy (or cetuximab) with curative intent (including preoperative or postoperative treatment)
| 3
|
[
"Planned",
"treatment",
"with",
"fractionated",
"(",
"≥15",
"treatments",
")",
"external",
"beam",
"radiotherapy",
"with",
"concurrent",
"chemotherapy",
"(",
"or",
"cetuximab",
")",
"with",
"curative",
"intent",
"(",
"including",
"preoperative",
"or",
"postoperative",
"treatment",
")"
] |
[
1,
1,
0,
0,
0,
0,
1,
0,
1,
1,
1,
0,
0,
1,
0,
0,
1,
0,
0,
1,
1,
0,
0,
1,
1,
1,
1,
0
] |
NCT01810588
|
1:29:cancer
|
Chronic myelogenous leukemia in chronic
| 3
|
[
"Chronic",
"myelogenous",
"leukemia",
"in",
"chronic"
] |
[
3,
3,
3,
0,
0
] |
NCT02524379
|
89:109:treatment
|
Currently involved in another non-observational SCI research study or receiving another investigational drug
| 3
|
[
"Currently",
"involved",
"in",
"another",
"non-observational",
"SCI",
"research",
"study",
"or",
"receiving",
"another",
"investigational",
"drug"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02128802
|
1:29:chronic_disease
|
Human Immunodeficiency Virus
| 3
|
[
"Human",
"Immunodeficiency",
"Virus"
] |
[
2,
2,
2
] |
NCT02323126
|
1:11:cancer,12:17:cancer,19:33:cancer
|
EGFR T790M NSCLC (adenocarcinoma)
| 3
|
[
"EGFR",
"T790M",
"NSCLC",
"(",
"adenocarcinoma",
")"
] |
[
3,
3,
3,
0,
3,
0
] |
NCT03115775
|
1:9:chronic_disease
|
Diabetes
| 3
|
[
"Diabetes"
] |
[
2
] |
NCT02346929
|
1:26:chronic_disease
|
Acute psychiatric illness
| 3
|
[
"Acute",
"psychiatric",
"illness"
] |
[
2,
2,
2
] |
NCT01600040
|
29:36:cancer,
|
Subjects with the following cancers are eligible if diagnosed and treated within the past 5 years
| 3
|
[
"Subjects",
"with",
"the",
"following",
"cancers",
"are",
"eligible",
"if",
"diagnosed",
"and",
"treated",
"within",
"the",
"past",
"5",
"years"
] |
[
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02161380
|
12:18:cancer,,58:63:cancer,67:90:cancer
|
History of cancer within five years other than localized basal or squamous cell carcinoma not near the orbital area
| 3
|
[
"History",
"of",
"cancer",
"within",
"five",
"years",
"other",
"than",
"localized",
"basal",
"or",
"squamous",
"cell",
"carcinoma",
"not",
"near",
"the",
"orbital",
"area"
] |
[
0,
0,
3,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0
] |
NCT02428205
|
38:46:chronic_disease
|
Non-autism learning disability (e.g. dyslexia)
| 3
|
[
"Non-autism",
"learning",
"disability",
"(",
"e.g",
".",
"dyslexia",
")"
] |
[
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT02140554
|
35:44:chronic_disease,46:51:chronic_disease,53:59:chronic_disease,64:83:chronic_disease
|
Clinically significant and active bacterial, viral, fungal, or parasitic infection
| 3
|
[
"Clinically",
"significant",
"and",
"active",
"bacterial",
",",
"viral",
",",
"fungal",
",",
"or",
"parasitic",
"infection"
] |
[
0,
0,
0,
0,
2,
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT03096366
|
1:28:chronic_disease
|
Peripheral vascular disease
| 3
|
[
"Peripheral",
"vascular",
"disease"
] |
[
2,
2,
2
] |
NCT01874860
|
1:26:treatment,
|
Prior cetuximab treatment within the 6 months of study initiation
| 3
|
[
"Prior",
"cetuximab",
"treatment",
"within",
"the",
"6",
"months",
"of",
"study",
"initiation"
] |
[
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03125902
|
14:30:chronic_disease,32:52:chronic_disease,57:64:chronic_disease
|
Uncontrolled pleural effusion, pericardial effusion, or ascites
| 3
|
[
"Uncontrolled",
"pleural",
"effusion",
",",
"pericardial",
"effusion",
",",
"or",
"ascites"
] |
[
0,
2,
2,
0,
2,
2,
0,
0,
2
] |
NCT01433965
|
,,31:46:treatment
|
between 6 months to 10 months post transplant
| 3
|
[
"between",
"6",
"months",
"to",
"10",
"months",
"post",
"transplant"
] |
[
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01494662
|
60:71:chronic_disease,93:100:treatment,,,163:175:treatment
|
In cohort 2, eligible patients will include those who have CNS disease that is amenable for surgery (typically < 3 brain metastases and with planned resection by neurosurgery)
| 3
|
[
"In",
"cohort",
"2",
",",
"eligible",
"patients",
"will",
"include",
"those",
"who",
"have",
"CNS",
"disease",
"that",
"is",
"amenable",
"for",
"surgery",
"(",
"typically",
"<",
"3",
"brain",
"metastases",
"and",
"with",
"planned",
"resection",
"by",
"neurosurgery",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT00734877
|
24:54:chronic_disease,,
|
Patients must not have light chain deposition disease or creatinine > 3 mg/dl
| 3
|
[
"Patients",
"must",
"not",
"have",
"light",
"chain",
"deposition",
"disease",
"or",
"creatinine",
">",
"3",
"mg/dl"
] |
[
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT01280669
|
13:20:chronic_disease,,,
|
Have active uveitis, defined as having at least 1+ Vitreous Haze and/or at least 1+ Vitreous Cell Count (SUN scale)
| 3
|
[
"Have",
"active",
"uveitis",
",",
"defined",
"as",
"having",
"at",
"least",
"1+",
"Vitreous",
"Haze",
"and/or",
"at",
"least",
"1+",
"Vitreous",
"Cell",
"Count",
"(",
"SUN",
"scale",
")"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02314221
|
8:18:chronic_disease,,
|
Severe spasticity (defined by an Ashworth score of >4.0 or clinical impression of the study physician or physical therapist)
| 3
|
[
"Severe",
"spasticity",
"(",
"defined",
"by",
"an",
"Ashworth",
"score",
"of",
">",
"4.0",
"or",
"clinical",
"impression",
"of",
"the",
"study",
"physician",
"or",
"physical",
"therapist",
")"
] |
[
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00258427
|
21:35:chronic_disease
|
with a diagnosis of Fanconi anemia
| 3
|
[
"with",
"a",
"diagnosis",
"of",
"Fanconi",
"anemia"
] |
[
0,
0,
0,
0,
2,
2
] |
NCT02055053
|
12:29:allergy_name
|
Allergy to local anesthetics
| 3
|
[
"Allergy",
"to",
"local",
"anesthetics"
] |
[
0,
0,
4,
4
] |
NCT00670358
|
1:19:chronic_disease
|
Cardiac arrhythmia
| 3
|
[
"Cardiac",
"arrhythmia"
] |
[
2,
2
] |
NCT01200940
|
1:9:chronic_disease,,,,
|
Diabetes (fasting blood glucose of 126 mg/dl or higher, or 2-hour blood glucose of 200 or higher on oral glucose tolerance testing)
| 3
|
[
"Diabetes",
"(",
"fasting",
"blood",
"glucose",
"of",
"126",
"mg/dl",
"or",
"higher",
",",
"or",
"2-hour",
"blood",
"glucose",
"of",
"200",
"or",
"higher",
"on",
"oral",
"glucose",
"tolerance",
"testing",
")"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02792036
|
12:39:chronic_disease
|
Absence of anterior hyaloid detachment
| 3
|
[
"Absence",
"of",
"anterior",
"hyaloid",
"detachment"
] |
[
0,
0,
2,
2,
2
] |
NCT01624090
|
,,51:62:treatment
|
Platelets greater than or equal to 100,000/ mm^3 (transfusion independent)
| 3
|
[
"Platelets",
"greater",
"than",
"or",
"equal",
"to",
"100,000/",
"mm^3",
"(",
"transfusion",
"independent",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT00432094
|
,,,,55:60:treatment,
|
WBC > 2.5 x 10^9/L with an ANC > 1.5 x 10^9/L and off G-CSF for 3 days
| 3
|
[
"WBC",
">",
"2.5",
"x",
"10^9/L",
"with",
"an",
"ANC",
">",
"1.5",
"x",
"10^9/L",
"and",
"off",
"G-CSF",
"for",
"3",
"days"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02091999
|
,,,79:106:treatment
|
International normal ratio (INR) < 1.3 or ≤ institutional ULN (or ≤ 3.0 if on therapeutic anticoagulation)
| 3
|
[
"International",
"normal",
"ratio",
"(",
"INR",
")",
"<",
"1.3",
"or",
"≤",
"institutional",
"ULN",
"(",
"or",
"≤",
"3.0",
"if",
"on",
"therapeutic",
"anticoagulation",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT01530958
|
1:25:chronic_disease,
|
severe visual impairment preventing use of a touch-tone telephone keypad
| 3
|
[
"severe",
"visual",
"impairment",
"preventing",
"use",
"of",
"a",
"touch-tone",
"telephone",
"keypad"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02797795
|
,24:64:treatment
|
Receipt of more than 5 prior regimens of cytotoxic chemotherapy (unless prior approval is granted by the Sponsor)
| 3
|
[
"Receipt",
"of",
"more",
"than",
"5",
"prior",
"regimens",
"of",
"cytotoxic",
"chemotherapy",
"(",
"unless",
"prior",
"approval",
"is",
"granted",
"by",
"the",
"Sponsor",
")"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01707394
|
30:65:treatment
|
Subjects with any functional CVAD (Central Venous Access Device) in the upper or lower venous system
| 3
|
[
"Subjects",
"with",
"any",
"functional",
"CVAD",
"(",
"Central",
"Venous",
"Access",
"Device",
")",
"in",
"the",
"upper",
"or",
"lower",
"venous",
"system"
] |
[
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00632853
|
10:22:treatment
|
No prior radiotherapy
| 3
|
[
"No",
"prior",
"radiotherapy"
] |
[
0,
0,
1
] |
NCT02983240
|
13:37:treatment,43:52:treatment,54:62:treatment,64:71:treatment
|
long acting oral maintenance opiates i.e. methadone, Suboxone, Subutex
| 3
|
[
"long",
"acting",
"oral",
"maintenance",
"opiates",
"i.e",
".",
"methadone",
",",
"Suboxone",
",",
"Subutex"
] |
[
0,
0,
1,
1,
1,
0,
0,
1,
0,
1,
0,
1
] |
NCT03006302
|
12:26:cancer
|
Documented adenocarcinoma of the pancreas
| 3
|
[
"Documented",
"adenocarcinoma",
"of",
"the",
"pancreas"
] |
[
0,
3,
0,
0,
0
] |
NCT02660528
|
22:50:treatment
|
Currently taking any immunomodulating medications
| 3
|
[
"Currently",
"taking",
"any",
"immunomodulating",
"medications"
] |
[
0,
0,
0,
1,
1
] |
NCT01045148
|
1:27:cancer
|
Stage < T1b, T2c, T3 or T4 disease (AJCC 6th Edition, see Appendix II)
| 3
|
[
"Stage",
"<",
"T1b",
",",
"T2c",
",",
"T3",
"or",
"T4",
"disease",
"(",
"AJCC",
"6th",
"Edition",
",",
"see",
"Appendix",
"II",
")"
] |
[
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02307058
|
42:54:treatment
|
It must be started prior to the start of radiotherapy
| 3
|
[
"It",
"must",
"be",
"started",
"prior",
"to",
"the",
"start",
"of",
"radiotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00285935
|
45:75:chronic_disease
|
No current (in the last month) diagnosis of Post-Traumatic Stress Disorder (DSM-5 criteria)
| 3
|
[
"No",
"current",
"(",
"in",
"the",
"last",
"month",
")",
"diagnosis",
"of",
"Post-Traumatic",
"Stress",
"Disorder",
"(",
"DSM-5",
"criteria",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0
] |
NCT02596776
|
,,,,,,117:121:chronic_disease
|
Insulin resistance Fasting blood sugar >126, or 2 hr glu >200, but with A1C<7.5 (i.e. we will include subjects with T2DM on no meds and with good glycemic control)
| 3
|
[
"Insulin",
"resistance",
"Fasting",
"blood",
"sugar",
">",
"126",
",",
"or",
"2",
"hr",
"glu",
">",
"200",
",",
"but",
"with",
"A1C",
"<",
"7.5",
"(",
"i.e",
".",
"we",
"will",
"include",
"subjects",
"with",
"T2DM",
"on",
"no",
"meds",
"and",
"with",
"good",
"glycemic",
"control",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02939742
|
,71:96:treatment,,
|
Gestational age of membrane rupture and initiation of first course of antenatal corticosteroids between 23 5/7 - 32 5/7 weeks
| 3
|
[
"Gestational",
"age",
"of",
"membrane",
"rupture",
"and",
"initiation",
"of",
"first",
"course",
"of",
"antenatal",
"corticosteroids",
"between",
"23",
"5/7",
"-",
"32",
"5/7",
"weeks"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02679560
|
33:50:allergy_name
|
History of allergic reaction to local anesthetics
| 3
|
[
"History",
"of",
"allergic",
"reaction",
"to",
"local",
"anesthetics"
] |
[
0,
0,
0,
0,
0,
4,
4
] |
NCT02167009
|
1:15:chronic_disease
|
Bladder atonia
| 3
|
[
"Bladder",
"atonia"
] |
[
2,
2
] |
NCT03165227
|
,,,,175:200:treatment
|
eGFR (Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI] formula) ≥ 20 and < 75 ml/min/1.73 m2 at Visit 1 measured by the central laboratory and no planned start of renal replacement therapy during the trial
| 3
|
[
"eGFR",
"(",
"Chronic",
"Kidney",
"Disease",
"Epidemiology",
"Collaboration",
"[",
"CKD-EPI",
"]",
"formula",
")",
"≥",
"20",
"and",
"<",
"75",
"ml/min/1.73",
"m2",
"at",
"Visit",
"1",
"measured",
"by",
"the",
"central",
"laboratory",
"and",
"no",
"planned",
"start",
"of",
"renal",
"replacement",
"therapy",
"during",
"the",
"trial"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0
] |
NCT03001765
|
38:86:chronic_disease
|
History of or suspected diagnosis of Postural Orthostatic Tachycardia Syndrome (POTS)
| 3
|
[
"History",
"of",
"or",
"suspected",
"diagnosis",
"of",
"Postural",
"Orthostatic",
"Tachycardia",
"Syndrome",
"(",
"POTS",
")"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0
] |
NCT02259621
|
47:55:chronic_disease,57:81:chronic_disease,92:106:chronic_disease,114:134:chronic_disease,150:169:treatment,171:180:chronic_disease,195:213:treatment
|
Subjects are permitted to enroll if they have vitiligo, type I diabetes mellitus, residual hypothyroidism due to autoimmune condition only requiring hormone replacement, psoriasis not requiring systemic treatment, or conditions not expected to recur in the absence of an external trigger
| 3
|
[
"Subjects",
"are",
"permitted",
"to",
"enroll",
"if",
"they",
"have",
"vitiligo",
",",
"type",
"I",
"diabetes",
"mellitus",
",",
"residual",
"hypothyroidism",
"due",
"to",
"autoimmune",
"condition",
"only",
"requiring",
"hormone",
"replacement",
",",
"psoriasis",
"not",
"requiring",
"systemic",
"treatment",
",",
"or",
"conditions",
"not",
"expected",
"to",
"recur",
"in",
"the",
"absence",
"of",
"an",
"external",
"trigger"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
2,
0,
0,
2,
0,
0,
2,
2,
0,
0,
1,
1,
0,
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01572480
|
62:89:cancer
|
Patients must have histologically or cytologically confirmed Smoldering Multiple Myeloma confirmed by the Laboratory of Pathology, NCI or the Department of Laboratory Medicine, CC based on the International Myeloma Working Group Criteria
| 3
|
[
"Patients",
"must",
"have",
"histologically",
"or",
"cytologically",
"confirmed",
"Smoldering",
"Multiple",
"Myeloma",
"confirmed",
"by",
"the",
"Laboratory",
"of",
"Pathology",
",",
"NCI",
"or",
"the",
"Department",
"of",
"Laboratory",
"Medicine",
",",
"CC",
"based",
"on",
"the",
"International",
"Myeloma",
"Working",
"Group",
"Criteria"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01697371
|
1:19:treatment
|
Prior radiotherapy that would results in overlap of radiation fields
| 3
|
[
"Prior",
"radiotherapy",
"that",
"would",
"results",
"in",
"overlap",
"of",
"radiation",
"fields"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02703272
|
27:52:treatment,58:66:treatment
|
Participants with ongoing anticoagulation treatment with warfarin or equivalent vitamin K antagonists (example phenprocoumon)
| 3
|
[
"Participants",
"with",
"ongoing",
"anticoagulation",
"treatment",
"with",
"warfarin",
"or",
"equivalent",
"vitamin",
"K",
"antagonists",
"(",
"example",
"phenprocoumon",
")"
] |
[
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02210650
|
1:27:chronic_disease
|
renal anatomical disorders
| 3
|
[
"renal",
"anatomical",
"disorders"
] |
[
2,
2,
2
] |
NCT02422641
|
38:50:allergy_name
|
Prior allergy or adverse reaction to methotrexate
| 3
|
[
"Prior",
"allergy",
"or",
"adverse",
"reaction",
"to",
"methotrexate"
] |
[
0,
0,
0,
0,
0,
0,
4
] |
NCT03176979
|
,12:27:allergy_name
|
Women with iodine contrast allergy
| 3
|
[
"Women",
"with",
"iodine",
"contrast",
"allergy"
] |
[
0,
0,
4,
4,
0
] |
NCT02635893
|
5:25:chronic_disease
|
Any debilitating disease prior to the SCI that caused exercise intolerance
| 3
|
[
"Any",
"debilitating",
"disease",
"prior",
"to",
"the",
"SCI",
"that",
"caused",
"exercise",
"intolerance"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02169739
|
32:38:chronic_disease,45:55:treatment,57:67:chronic_disease,69:92:chronic_disease
|
Other likely specific cause of stroke (e.g. dissection, vasculitis, prothrombotic diathesis, drug abuse)
| 3
|
[
"Other",
"likely",
"specific",
"cause",
"of",
"stroke",
"(",
"e.g",
".",
"dissection",
",",
"vasculitis",
",",
"prothrombotic",
"diathesis",
",",
"drug",
"abuse",
")"
] |
[
0,
0,
0,
0,
0,
2,
0,
0,
0,
1,
0,
2,
0,
2,
2,
0,
0,
0,
0
] |
NCT02312570
|
39:44:chronic_disease,60:70:chronic_disease,75:88:chronic_disease
|
Gross clinical infection at the study ulcer site including cellulitis and osteomyelitis
| 3
|
[
"Gross",
"clinical",
"infection",
"at",
"the",
"study",
"ulcer",
"site",
"including",
"cellulitis",
"and",
"osteomyelitis"
] |
[
0,
0,
0,
0,
0,
0,
2,
0,
0,
2,
0,
2
] |
NCT02881242
|
,,66:76:treatment,
|
systemic corticosteroids greater than the equivalent of 10 mg of prednisone per day within 4 weeks of enrollment
| 3
|
[
"systemic",
"corticosteroids",
"greater",
"than",
"the",
"equivalent",
"of",
"10",
"mg",
"of",
"prednisone",
"per",
"day",
"within",
"4",
"weeks",
"of",
"enrollment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01871727
|
13:28:chronic_disease,47:56:treatment,68:98:treatment,107:136:chronic_disease,138:152:chronic_disease,167:185:chronic_disease,196:211:chronic_disease,216:242:chronic_disease
|
Significant cardiac disease requiring ongoing treatment, including congestive heart failure (CHF), severe coronary artery disease (CAD), cardiomyopathy, uncontrolled cardiac arrhythmia, unstable angina pectoris, or myocardial infarction (MI)
| 3
|
[
"Significant",
"cardiac",
"disease",
"requiring",
"ongoing",
"treatment",
",",
"including",
"congestive",
"heart",
"failure",
"(",
"CHF",
")",
",",
"severe",
"coronary",
"artery",
"disease",
"(",
"CAD",
")",
",",
"cardiomyopathy",
",",
"uncontrolled",
"cardiac",
"arrhythmia",
",",
"unstable",
"angina",
"pectoris",
",",
"or",
"myocardial",
"infarction",
"(",
"MI",
")"
] |
[
0,
2,
2,
0,
0,
1,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0
] |
NCT01562626
|
1:5:treatment
|
5-FU
| 3
|
[
"5-FU"
] |
[
1
] |
NCT01464164
|
,,,,182:193:treatment
|
Males must agree to use a latex condom during any sexual contact with females of childbearing potential while participating in the study and for 112 days following the last dose of sotatercept
| 3
|
[
"Males",
"must",
"agree",
"to",
"use",
"a",
"latex",
"condom",
"during",
"any",
"sexual",
"contact",
"with",
"females",
"of",
"childbearing",
"potential",
"while",
"participating",
"in",
"the",
"study",
"and",
"for",
"112",
"days",
"following",
"the",
"last",
"dose",
"of",
"sotatercept"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02473250
|
1:10:cancer
|
lymphomas
| 3
|
[
"lymphomas"
] |
[
3
] |
NCT02446457
|
60:72:treatment
|
be willing and able to comply with the requirements of the REMS program
| 3
|
[
"be",
"willing",
"and",
"able",
"to",
"comply",
"with",
"the",
"requirements",
"of",
"the",
"REMS",
"program"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02666378
|
14:40:chronic_disease
|
Uncontrolled serious concurrent illness
| 3
|
[
"Uncontrolled",
"serious",
"concurrent",
"illness"
] |
[
0,
2,
2,
2
] |
NCT02446457
|
43:58:treatment,60:95:treatment,99:115:treatment
|
subjects that require intermittent use of bronchodilators, local steroid injections or inhaled or topical steroids
| 3
|
[
"subjects",
"that",
"require",
"intermittent",
"use",
"of",
"bronchodilators",
",",
"local",
"steroid",
"injections",
"or",
"inhaled",
"or",
"topical",
"steroids"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1,
1,
1,
0,
1,
1
] |
NCT02324582
|
1:20:chronic_disease
|
active tuberculosis
| 3
|
[
"active",
"tuberculosis"
] |
[
2,
2
] |
NCT01011777
|
,24:51:treatment
|
at least 2 years after bladder neck reconstruction
| 3
|
[
"at",
"least",
"2",
"years",
"after",
"bladder",
"neck",
"reconstruction"
] |
[
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01684397
|
13:34:treatment,
|
Received an investigational agent within 30 days prior to enrollment
| 3
|
[
"Received",
"an",
"investigational",
"agent",
"within",
"30",
"days",
"prior",
"to",
"enrollment"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01189786
|
17:39:chronic_disease,,,,,
|
The presence of severe hepatic disease (direct bilirubin >3x upper limit of normal and AST > 5x upper limit of normal)
| 3
|
[
"The",
"presence",
"of",
"severe",
"hepatic",
"disease",
"(",
"direct",
"bilirubin",
">",
"3x",
"upper",
"limit",
"of",
"normal",
"and",
"AST",
">",
"5x",
"upper",
"limit",
"of",
"normal",
")"
] |
[
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02635360
|
1:21:cancer,25:48:cancer,92:108:treatment
|
basal cell carcinoma or squamous cell carcinoma of the skin that has undergone potentially curative therapy is permissable
| 3
|
[
"basal",
"cell",
"carcinoma",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
"that",
"has",
"undergone",
"potentially",
"curative",
"therapy",
"is",
"permissable"
] |
[
3,
3,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0
] |
NCT02451553
|
14:35:chronic_disease,60:78:chronic_disease,157:178:chronic_disease,203:222:chronic_disease,260:294:chronic_disease
|
Known active hepatitis B infection (defined as presence of hepatitis B [HepB] surface antigen [sAg] and/or Hep B deoxyribonucleic acid [DNA]), known active hepatitis C infection (defined as presence of hepatitis C [Hep C] ribonucleic acid [RNA]) and/or known human immunodeficiency virus (HIV) carrier
| 3
|
[
"Known",
"active",
"hepatitis",
"B",
"infection",
"(",
"defined",
"as",
"presence",
"of",
"hepatitis",
"B",
"[",
"HepB",
"]",
"surface",
"antigen",
"[",
"sAg",
"]",
"and/or",
"Hep",
"B",
"deoxyribonucleic",
"acid",
"[",
"DNA",
"]",
")",
",",
"known",
"active",
"hepatitis",
"C",
"infection",
"(",
"defined",
"as",
"presence",
"of",
"hepatitis",
"C",
"[",
"Hep",
"C",
"]",
"ribonucleic",
"acid",
"[",
"RNA",
"]",
")",
"and/or",
"known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"carrier"
] |
[
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0
] |
NCT02857673
|
,,49:57:chronic_disease,59:68:chronic_disease,73:100:chronic_disease
|
Primary caregiver of a child under age 7 with a physical, emotional, or behavioral health condition
| 3
|
[
"Primary",
"caregiver",
"of",
"a",
"child",
"under",
"age",
"7",
"with",
"a",
"physical",
",",
"emotional",
",",
"or",
"behavioral",
"health",
"condition"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
2,
2,
2
] |
NCT02429934
|
24:45:treatment,64:73:treatment,78:90:chronic_disease
|
Subjects with positive quantiferon Gold test in the absence of treatment for tuberculosis
| 3
|
[
"Subjects",
"with",
"positive",
"quantiferon",
"Gold",
"test",
"in",
"the",
"absence",
"of",
"treatment",
"for",
"tuberculosis"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
1,
0,
2
] |
NCT02003222
|
32:54:treatment,47:54:treatment,163:179:treatment
|
Patient must be on combination antiretroviral therapy with minimal pharmacokinetic interactions with study therapy and minimal overlapping clinical toxicity with protocol therapy
| 3
|
[
"Patient",
"must",
"be",
"on",
"combination",
"antiretroviral",
"therapy",
"with",
"minimal",
"pharmacokinetic",
"interactions",
"with",
"study",
"therapy",
"and",
"minimal",
"overlapping",
"clinical",
"toxicity",
"with",
"protocol",
"therapy"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01968109
|
1:13:chronic_disease,15:25:chronic_disease,43:51:chronic_disease
|
Encephalitis, meningitis, or uncontrolled seizures in the year prior to informed consent
| 3
|
[
"Encephalitis",
",",
"meningitis",
",",
"or",
"uncontrolled",
"seizures",
"in",
"the",
"year",
"prior",
"to",
"informed",
"consent"
] |
[
2,
0,
2,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02176161
|
28:43:treatment
|
Able to swallow and retain oral medication
| 3
|
[
"Able",
"to",
"swallow",
"and",
"retain",
"oral",
"medication"
] |
[
0,
0,
0,
0,
0,
1,
1
] |
NCT01886105
|
28:46:treatment
|
Patients who have received prior radiotherapy to all areas of current active disease
| 3
|
[
"Patients",
"who",
"have",
"received",
"prior",
"radiotherapy",
"to",
"all",
"areas",
"of",
"current",
"active",
"disease"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.